In line with these observations, neuregulin-1 (NRG1), the primary ligand for HER3, emerges as the strongest mitogenic factor in NSCLC [171] inducing HER2/HER3 coupling and signaling, thus supporting cancer cell survival, independently from the EGFR pathway [172]. This evidence concerns the gene ERBB3 and cancer.